120 related articles for article (PubMed ID: 23430442)
1. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.
Sun C; Sun L; Li Y; Kang X; Zhang S; Liu Y
Med Oncol; 2013 Jun; 30(2):503. PubMed ID: 23430442
[TBL] [Abstract][Full Text] [Related]
2. DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.
Qin J; Ji J; Deng R; Tang J; Yang F; Feng GK; Chen WD; Wu XQ; Qian XJ; Ding K; Zhu XF
Oncotarget; 2015 Mar; 6(9):6944-58. PubMed ID: 25749514
[TBL] [Abstract][Full Text] [Related]
3. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
[TBL] [Abstract][Full Text] [Related]
4. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.
Hütz K; Mejías-Luque R; Farsakova K; Ogris M; Krebs S; Anton M; Vieth M; Schüller U; Schneider MR; Blum H; Wagner E; Jung A; Gerhard M
Carcinogenesis; 2014 Apr; 35(4):942-50. PubMed ID: 24325912
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
6. Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression.
Zhao X; Sun B; Sun D; Liu T; Che N; Gu Q; Dong X; Li R; Liu Y; Li J
Oncol Rep; 2015 Jan; 33(1):149-56. PubMed ID: 25339068
[TBL] [Abstract][Full Text] [Related]
7. SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.
Lundberg IV; Löfgren Burström A; Edin S; Eklöf V; Öberg Å; Stenling R; Palmqvist R; Wikberg ML
PLoS One; 2014; 9(7):e101957. PubMed ID: 25010701
[TBL] [Abstract][Full Text] [Related]
8. Sox2: A Regulatory Factor in Tumorigenesis and Metastasis.
Chaudhary S; Islam Z; Mishra V; Rawat S; Ashraf GM; Kolatkar PR
Curr Protein Pept Sci; 2019; 20(6):495-504. PubMed ID: 30907312
[TBL] [Abstract][Full Text] [Related]
9. Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.
Baek JW; Nam AR; Kim K; Kim PH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474121
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.
Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
[TBL] [Abstract][Full Text] [Related]
11. Indirect Mechanisms of Transcription Factor-Mediated Gene Regulation during Cell Fate Changes.
Larcombe MR; Hsu S; Polo JM; Knaupp AS
Adv Genet (Hoboken); 2022 Dec; 3(4):2200015. PubMed ID: 36911290
[TBL] [Abstract][Full Text] [Related]
12. SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation.
Xie Q; Hua X; Huang C; Liao X; Tian Z; Xu J; Zhao Y; Jiang G; Huang H; Huang C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293387
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer.
Shonibare Z; Monavarian M; O'Connell K; Altomare D; Shelton A; Mehta S; Jaskula-Sztul R; Phaeton R; Starr MD; Whitaker R; Berchuck A; Nixon AB; Arend RC; Lee NY; Miller CR; Hempel N; Mythreye K
Cell Rep; 2022 Jul; 40(4):111066. PubMed ID: 35905726
[TBL] [Abstract][Full Text] [Related]
14. H2AFX might be a prognostic biomarker for hepatocellular carcinoma.
Hu H; Zhong T; Jiang S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1684. PubMed ID: 35903980
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC.
Sun G; Zheng W; Tan P; Zhou J; Tang W; Cao H; Liu L; Shi X; Li Z; Zhang W
Front Genet; 2022; 13():900306. PubMed ID: 35812745
[No Abstract] [Full Text] [Related]
16. De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet.
Winkler S; Winkler I; Figaschewski M; Tiede T; Nordheim A; Kohlbacher O
BMC Bioinformatics; 2022 Apr; 23(1):139. PubMed ID: 35439941
[TBL] [Abstract][Full Text] [Related]
17. Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.
Luo X; Ji X; Xie M; Zhang T; Wang Y; Sun M; Huang W; Xia L
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267473
[TBL] [Abstract][Full Text] [Related]
18. SOX2 mediates metabolic reprogramming of prostate cancer cells.
de Wet L; Williams A; Gillard M; Kregel S; Lamperis S; Gutgesell LC; Vellky JE; Brown R; Conger K; Paner GP; Wang H; Platz EA; De Marzo AM; Mu P; Coloff JL; Szmulewitz RZ; Vander Griend DJ
Oncogene; 2022 Feb; 41(8):1190-1202. PubMed ID: 35067686
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma.
Tseng CH; Lu PH; Wang YP; Chang JYF
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055392
[TBL] [Abstract][Full Text] [Related]
20. Multi-Omics Analysis of
Seok J; Gil M; Dayem AA; Saha SK; Cho SG
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
